# FDA Inspection 1029080 - American National Red Cross, Penn Jersey Region - September 20, 2017

Source: https://www.keypedia.com/records/fda_inspections/american-national-red-cross-penn-jersey-region/33bed01a-9e0b-4b1a-9c22-4a9fd587caa2
Source feed: FDA_Inspections

> FDA Inspection 1029080 for American National Red Cross, Penn Jersey Region on September 20, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1029080
- Company Name: American National Red Cross, Penn Jersey Region
- Inspection Date: 2017-09-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1193508 - 2022-12-02](https://www.keypedia.com/records/fda_inspections/american-national-red-cross-penn-jersey-region/f2c9cc3f-bc9a-40b8-ba1d-c5585c6964b8)
- [FDA Inspection 1193508 - 2022-12-02](https://www.keypedia.com/records/fda_inspections/american-national-red-cross-penn-jersey-region/b5df98b1-1836-434c-823f-8c4f92f8e138)
- [FDA Inspection 1193508 - 2022-12-02](https://www.keypedia.com/records/fda_inspections/american-national-red-cross-penn-jersey-region/20125465-ec60-45b3-bfa5-4078e8dfe243)
- [FDA Inspection 944166 - 2015-10-09](https://www.keypedia.com/records/fda_inspections/american-national-red-cross-penn-jersey-region/24e30e35-9ec2-4836-b0d3-265b3483b23f)
- [FDA Inspection 903131 - 2014-10-23](https://www.keypedia.com/records/fda_inspections/american-national-red-cross-penn-jersey-region/f21de215-f34d-4c67-ae96-b09dcef4ec42)

Company: https://www.keypedia.com/companies/american-national-red-cross-penn-jersey-region/7d2928f2-8d2a-48db-b0df-6c8a10016030

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d